Projects per year
Personal profile
Biography
Dr David Pook is a Medical Oncologist working with the Prostate Cancer Research Program in the Department of Anatomy and Developmental Biology. Dr Pook's research work is directed towards developing a better understanding of castrate resistant prostate cancer. He is also a lead investigator in the VCA funded CAPTIV prostate cancer research program.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2011 2024
A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïvepts with bone predominant metastatic castration-resistant prostate cancer (CRPC)
20/06/19 → 19/06/24
Project: Research
A Phase Iii, Multicenter, Randomized Study Of Atezolizumab (Anti−Pdl1 Antibody) In Combination With Enzalutamide Versus Enzalutamide Alone In Patients With Metastatic Castrationresistant Prostate Cancer After Failure Of An Androgen Synthesis Inhibitor And Failure Of, Ineligibility For, Or Refusal Of A Taxane Regimen
20/05/19 → 19/05/24
Project: Research
Research Output 2008 2019
Enzalutamide with standard first-line therapy in metastatic prostate cancer
Davis, I. D., Martin, A. J., Stockler, M. R., Begbie, S., Chi, K. N., Chowdhury, S., Coskinas, X., Frydenberg, M., Hague, W. E., Horvath, L. G., Joshua, A. M., Lawrence, N. J., Marx, G., McCaffrey, J., McDermott, R., McJannett, M., North, S. A., Parnis, F., Parulekar, W., Pook, D. W. & 13 others, , 11 Jul 2019, In : New England Journal of Medicine. 381, 2, p. 121-131 11 p.Research output: Contribution to journal › Article › Research › peer-review
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer
Porter, L. H., Lawrence, M. G., Wang, H., Clark, A. K., Bakshi, A., Obinata, D., Goode, D., Papargiris, M., Clouston, D., Ryan, A., Norden, S., Corey, E., Nelson, P. S., Isaacs, J. T., Grummet, J., Kourambas, J., Sandhu, S., Murphy, D. G., Pook, D., Frydenberg, M. & 2 others, , 1 Aug 2019, In : Prostate. 79, 11, p. 1326-1337 12 p.Research output: Contribution to journal › Article › Research › peer-review
Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer
Kwan, E. M., Fettke, H., Docanto, M. M., To, S. Q., Bukczynska, P., Mant, A., Pook, D., Ng, N., Graham, L. J. K., Mangiola, S., Segelov, E., Mahon, K., Davis, I. D., Parente, P., Pezaro, C., Todenhöfer, T., Horvath, L. G. & Azad, A. A., 15 May 2019, (Accepted/In press) In : European Urology Focus. 8 p.Research output: Contribution to journal › Article › Research › peer-review
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study
Ha, F. J., Spain, L., Dowling, A., Kwan, E. M., Pezaro, C., Day, D., Chia, P. L., Tran, B., Pook, D. & Weickhardt, A. J., 30 Jan 2019, (Accepted/In press) In : Asia-Pacific Journal of Clinical Oncology. 6 p.Research output: Contribution to journal › Article › Research › peer-review
Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC)
Kwan, E. M., To, S. Q. G., Fettke, H. C., Docanto, M., Bukczynska, P., Mant, A. M., Pook, D. W., Ng, N., Graham, L. J. K., Segelov, E., Mahon, K. L., Davis, I., Parente, P., Pezaro, C., Horvath, L. G. & Azad, A., 1 Mar 2019, In : Journal of Clinical Oncology. 37, 7 Suppl, p. 188 1 p.Research output: Contribution to journal › Meeting Abstract › Other › peer-review